Q.BEYOND AG/ DE0005137004 /
2024-05-08 5:22:11 PM | Chg. -0.03 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.67EUR | -3.58% | 3,574 Turnover: 2,406.59 |
-Bid Size: - | -Ask Size: - | 90.94 mill.EUR | 0.00% | 9.13 |
GlobeNewswire
8:00 AM
MC2 Therapeutics Receives Positive Feedback from FDA pre-IND Meeting and Updates on Indication Expan...
GlobeNewswire
7:00 AM
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chroni...
GlobeNewswire
05-09
Beyond, Inc. to Participate in 19th Annual Needham Technology, Media, and Consumer Conference
GlobeNewswire
05-01
Beyond Inc. Announces Expanded Investment in Salesforce Solutions to Drive Richer Customer Engagemen...
GlobeNewswire
05-01
Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxi...
GlobeNewswire
04-26
Melco reaffirms commitment to sustainability in 2023 RISE to go Above & Beyond report
GlobeNewswire
04-25
New Report Pins 6G Success on Novel Benchmarks Extending Beyond Speed, Latency, and Mobility
GlobeNewswire
04-18
Beyond IV, the Fourth Generation of the Beyond Burger® and Beyond Beef®, Debuts at Grocery Stores Ac...
GlobeNewswire
04-16
Beyond, Inc. Scheduled to Release First Quarter Financial Results on May 6, with a Premarket Call on...
GlobeNewswire
04-03
Stephen Samuel: Building Success Beyond Pharmaceuticals with Evolve Realty & Development Corp.
GlobeNewswire
03-28
Beyond Meat® Unveils New and Expanded Line of Beyond Crumbles, Now Certified by the American Heart A...